当前位置: 首页 > 期刊 > 《糖尿病新世界》 > 20203
编号:13509912
温针疗法治疗糖尿病周围神经病变临床疗效观察(1)
http://www.100md.com 2020年2月1日 《糖尿病新世界》 20203
     [摘要] 目的 探究应用温针疗法治疗糖尿病周围神经病变临床疗效。方法 于2018年2月—2019年1月期间择取该院收治的68例糖尿病周围神经患者开展课题研究,将其随机划分为两组进行治疗并比较其临床疗效。调研组患者应用温针疗法,常规组患者注射弥可保治疗。结果 调研组患者中共计有19例得到显效治疗,11例得到有效治疗,临床疗效优于常规组患者,组间差异有统计学意义(χ2=9.827,P<0.05);调研组患者接受治疗后神经传导速度高于常规组患者,差异有统计学意义(t=9.852、9.958,P<0.05)。结论 利用温针疗法治疗糖尿病周围神经病变疾病疗效好,可有效改善患者肢体神经传导,建议在临床中应用。

    [关键词] 温针疗法;糖尿病周围神经病变;临床疗效

    [中图分类号] R245 [文献标识码] A [文章编号] 1672-4062(2020)02(a)-0008-03

    Clinical Observation of Warm Needle Therapy for Diabetic Peripheral Neuropathy

    LIU Min

    Sanzhuang Central Medical Center, Donggang District, Rizhao, Shandong Province, 276821 China

    [Abstract] Objective To explore the clinical effect of warm needle therapy on diabetic peripheral neuropathy. Methods From February 2018 to January 2019, 68 patients with diabetic peripheral nerves treated in our hospital were selected to conduct research. They were randomly divided into two groups for treatment and their clinical efficacy was compared. Patients in the investigation group were treated with warm needle therapy, while patients in the conventional group were injected with mecobalamin. Results A total of 19 patients in the research group received significant treatment and 11 patients received effective treatment. The clinical efficacy was better than that of the conventional group, and there was a statistically significant difference between the groups(χ2=9.827,P<0.05). The patients in the research group received high nerve conduction velocity in the conventional group, and the difference was statistically significant(t=9.852,9.958,P<0.05). Conclusion The use of warm needle therapy for diabetic peripheral neuropathy is effective, and it can effectively improve the nerve conduction in the limbs of patients. It is recommended to apply it in clinical practice.

    [Key words] Warm needle therapy; Diabetic peripheral neuropathy; Clinical efficacy

    糖尿病周圍神经病变属于常见慢性并发症,其病因主要与血糖水平长期过高,导致神经组织代谢发生循环障碍,进而引发周围神经病变,目前其发病机制还处于研究阶段,临床并无治疗该疾病的特效药[1]。随着病程延长,患者会有肢体方面的感觉和运动障碍,该病具有起病缓慢且随着时间的延长,患者病情将会逐渐加重,将会导致患者在不知不觉中丧失生活自理能力,对于患者正常独立生活将会造成严重影响,患者必须依靠旁人照顾才能维持正常生活,对于患者而言是一个非常残酷的事实[2]。糖尿病神经病变患者通过对症治疗可在一定程度上延缓病变,阻止病情恶化,将病情控制在可控制范围内。该文旨在分析温针治疗糖尿病周围病变的临床疗效,特择选于2018年2月—2019年1月期间于该院收治的68例糖尿病周围神经患者进行临床研究,现报道如下。

    1 资料与方法

    1.1 一般资料

    择取该院收治的68例糖尿病周围神经患者开展课题研究,将其随机划分为调研组与常规组。纳入标准:患者经临床确诊为糖尿病周围神经病变;患者临床检查发生电生理异常。排除标准:患者处于哺乳期和妊娠期;患者自身肝脏和肾脏受到严重损害。调研组患者中女性患者:男性患者=19:15;年龄最大的患者有74岁,年龄最小的患者为58岁,平均年龄为(68.1±1.9)岁;糖尿病病程为(2~14)年,平均患病时间为(7.2±2.8)年。常规组患者中女性患者:男性患者=18:16;年龄最大的患者有73岁,年龄最小的患者为60岁,平均年龄为(67.5±1.8)岁,糖尿病病程为(2~13)年,平均患病时间为(7.1±2.5)年。两组患者在年龄、性别比例以及患病时间方面差异无统计学意义(P>0.05),有同期比较意义。开展研究前已向所有患者及其家属说明研究要求及治疗方案,所有患者均已签署知情同意文件。伦理委员会审核该文研究课题后,正式发放资质审核证书。, 百拇医药(刘敏)
1 2下一页